Adapting REhabilitation Delivery for Maximum Impact at Home
ReDI@Home
1 other identifier
interventional
112
1 country
1
Brief Summary
Hip and knee osteoarthritis (OA) is a burden of disability in adults, with many seeking total joint arthroplasty (TJA) to reduce their symptoms. Almost 50% of people screened for TJA are referred for further rehabilitation rather than TJA. However, access to community-based rehabilitation is limited for those living in rural settings. Recent advances in tele-rehabilitation using smart phone technology, widely available in rural areas, provides a means to access rehabilitation from home. ReDI@Home will examine the impact of home-based e-Rehabilitation, delivered via smart phone, for rural residents living with moderate to advanced OA. This randomized feasibility trial will compare 2 e-Rehabilitation programs (eRP) of varying intensity (eRP-LOw Intensity \[eRP-LO\] and eRP-HIgh Intensity \[eRP- HI\]). The investigators think that the eRP are feasible and that both eRP will improve OA self-management. However, eRP-HI will improve patient outcomes more than eRP-LO.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2021
CompletedStudy Start
First participant enrolled
December 9, 2021
CompletedFirst Posted
Study publicly available on registry
December 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 17, 2024
CompletedAugust 30, 2024
August 1, 2024
2.6 years
September 16, 2021
August 29, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Patient Activation Measure from baseline to post intervention and 6-months and 12-months
Self-management A13-item survey that assesses a person's underlying knowledge, skills and confidence integral to managing his or her own health and healthcare. PAM segments individuals into one of four activation levels along an empirically derived 100-point scale. Each level provides insight into an extensive array of health-related characteristics, including attitudes, motivators, and behaviors. Individuals with a low score do not yet understand the importance of their role in managing their own health, and have significant knowledge gaps and limited self-management skills. Individuals with higher scores are proactive with their health, have developed strong self management skills, and are resilient in times of stress or change.
At 0- weeks (pre-intervention), 9-weeks (post-intervention) and 6- and 12-months following randomization.
Secondary Outcomes (10)
Change in Hip Disability and Osteoarthritis Outcome Score from baseline to post intervention and 6-months and 12-months
At 0- weeks (pre-intervention), 9-weeks (post-intervention) and 6- and 12-months following randomization.
Change in Knee Osteoarthritis Outcome Score from baseline to post intervention and 6-months and 12-months
At 0- weeks (pre-intervention), 9-weeks (post-intervention) and 6- and 12-months following randomization.
Change in Intermittent and Constant Osteoarthritis Pain from baseline to post intervention and 6-months and 12-months
At 0- weeks (pre-intervention), 9-weeks (post-intervention) and 6- and 12-months following randomization.
Change in Hospital Anxiety and Depression Scale from baseline to post intervention and 6-months and 12-months
At 0- weeks (pre-intervention), 9-weeks (post-intervention) and 6- and 12-months following randomization.
Change in Pain Catastrophizing Scale from baseline to post intervention and 6-months and 12-months
At 0- weeks (pre-intervention), 9-weeks (post-intervention) and 6- and 12-months following randomization.
- +5 more secondary outcomes
Study Arms (2)
eRP-LOw Intensity (eRP-LO)
EXPERIMENTALan 8-week intervention that includes FOUR virtual visits with a physiotherapist
eRP-HIgh Intensity (eRP-HI)
EXPERIMENTALan 8-week intervention that includes EIGHT virtual visits with a physiotherapist
Interventions
Progressive resistance exercise program and self-management strategies. Participants will be provided with Theraband to progress exercise intensity, a FitBit to monitor physical activity, an audio-journal to promote self-reflection, and educational materials provided as part of usual OA care.
Progressive resistance exercise program and self-management strategies. Participants will be provided with Theraband to progress exercise intensity, a FitBit to monitor physical activity, an audio-journal to promote self-reflection, and educational materials provided as part of usual OA care.
Eligibility Criteria
You may qualify if:
- Present to the Edmonton or Camrose screening clinic with moderate to advanced hip or knee OA not eligible for TJA within one year (i.e., not RA, not currently waiting for TJA)
- Reside outside of metro Edmonton (defined by StatsCan)
- Access to a smart phone or tablet with embedded camera that can accept intervention software, with a current data plan in place and/or strong WiFi or ethernet connection\*
- English-speaking
- Are in need of guided exercise but are a functional community ambulator (with or without aids)
- Experience hip or knee pain multiple days a week
- Have activity limitations because of joint pain
You may not qualify if:
- Patients who are not eligible for TJA due to uncontrolled medical conditions (e.g., diabetes, hypertension) will be excluded due to safety concerns (i.e., undertaking exercise in their health state).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Edmonton Bone and Joint Centre
Edmonton, Alberta, T5E5R8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- ReDI@Home will be a randomized, parallel-arm, single-blind (clinical assessor) feasibility trial with participants randomized to eRP-HI or eRP-LO. An uneven block randomization sequence will be computer-generated with a 1:1 group allocation. Randomization will occur after the pre-intervention visit. The research coordinator will randomize participants after the equipment/software set-up and the pre-intervention assessment has been completed. The assigned intervention PT will contact participants to review the eRP and set up appointments as required based on group assignment. We will use one PT for all eRP-LO participants and up to 2 PTs to provide the eRP-HI intervention. Participants will have the same PT throughout, with visits scheduled during the day or early evening at PT and participant preference/availability, as per our previous COACH study.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2021
First Posted
December 20, 2021
Study Start
December 9, 2021
Primary Completion
July 17, 2024
Study Completion
July 17, 2024
Last Updated
August 30, 2024
Record last verified: 2024-08